Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as motexafin
gadolinium may make the tumor cells more sensitive to radiation therapy. Phase I trial to
study the effectiveness of motexafin gadolinium plus radiation therapy in treating children
who have newly diagnosed brain stem glioma